Jannik Sinner cleared of wrongdoing after failed drug tests, ITIA says

NEW YORK (Reuters) — World number one Jannik Sinner failed two drug tests in March but has been cleared of wrongdoing by an independent tribunal, the International Tennis Integrity Agency said on Tuesday days before the Italian is set to play at the U.S. Open.

The tribunal convened by Sport Resolutions accepted the Australian Open champion’s explanation that the anabolic agent clostebol entered his system from a member of his support team through massages and sports therapy.

Sinner said his physio, Giacomo Naldi, applied an over-the-counter spray containing clostebol to his own skin to treat a small finger wound and then administered massages between March 5-13 without using gloves, according to the ITIA.

Naldi was unaware that the product he had used on his cut contained clostebol, Sinner said. Clostebol is a steroid that can be used to build muscle mass.

Sinner’s first positive sample was taken on March 10 with a second eight days later.

A provisional suspension was applied with each positive test but he was allowed to keep playing after his team filed urgent appeals.

“Sinner’s results, prize money and ranking points from the ATP Masters 1000 event at Indian Wells, where the player tested positive in competition for clostebol, are disqualified, ” ITIA said in a statement, citing World Anti-Doping Code and Tennis Anti-Doping Programme regulations.

WADA said it would review the decision and reserved the right to appeal.

Sinner, who has always maintained his innocence, said the amount of clostebol found in his system was less than a billionth of a gram.

“I will now put this challenging and deeply unfortunate period behind me,” the 23-year-old said in a statement posted to social media.

The men’s ATP Tour said the saga “underscores the need for players and their entourages to take utmost care in the use of products or treatments.”

Sinner is the latest tennis player to become embroiled in a doping case, after twice major winner Simona Halep had her four-year doping ban cut to nine months this year after testing positive for a prohibited substance at the 2022 U.S. Open.

Halep argued she had unwittingly ingested the blood-booster roxadustat through contaminated nutritional supplements.